Cite
HARVARD Citation
Šenolt, L. et al. (n.d.). LB0004 Efficacy and safety of nnc0109-0012 (anti-IL-20 MAB) in patients with rheumatoid arthritis: Results from a phase 2a trial. Annals of the rheumatic diseases. p. 152. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Šenolt, L. et al. (n.d.). LB0004 Efficacy and safety of nnc0109-0012 (anti-IL-20 MAB) in patients with rheumatoid arthritis: Results from a phase 2a trial. Annals of the rheumatic diseases. p. 152. [Online].